Washington, DC-based FDA group attorney Barbara Binzak Blumenfeld was recently invited by the Food and Drug Law Institute (FDLI) to become a member of the Editorial Advisory Board of the Food and Drug Law Journal. Her term is for three years, effective May 1, 2016. The Journal is a key source of scholarly articles pertaining to food and drug law and FDA-regulated products. Published independently for many of its 70 years, the Journal is now co-published with Georgetown University Law Center. Barbara has been involved with FDLI for over thirteen years, serving on the Update Magazine Editorial Advisory Board and several committees. Her recent term as a member of the FDLI Board of Directors expired in December 2015.
FDLI is a not-for-profit 501(c)(3) organization that was founded in 1949. FDLI provides a forum for the discussion of issues related to all aspects of FDA-regulated products through conferences, webinars, and publications, but does not engage in advocacy activities.